Skip to content
DefDex

Federal award

DMS PHARMACEUTICAL GROUP INC

RL63

Contract

Obligated and Ceiling

Obligated (net)
$16,534.90
Ceiling (potential value, not spending)
$16,534.90
Current value
$16,534.90
Gross positive obligations
$16,534.90

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Owner company
DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
Reported parent
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Awarding agency
Department of Defense · sub-agency 97AS · office SPM200
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
424210 · DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS
PIID
RL63
Parent vehicle (IDV PIID)
SPM20005D0909
Award type code
C
Actions
1 · Sep 18, 2013 to Sep 18, 2013
Why it is listed
reviewed company, $10k or more

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 18, 2013FY20130—$16,534.90

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.